Smartphone App Fails FTC Test On Measuring Blood Pressure
This article was originally published in The Pink Sheet
Executive Summary
A settlement with "Instant Blood Pressure App" marketer Aura Labs marks FTC's latest enforcement against firms marketing OTC devices that make unsubstantiated health claims.
You may also be interested in...
Two Acne-Zapping Smartphone Apps Shut Down; FTC On Lookout For Others
Smartphones can do a lot of things, but curing acne is likely not one of them.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.